The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins

被引：1
作者：
Mishra, Prasun J. [1 ]
机构：
[1] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
PHARMACOGENOMICS | 2012年 / 13卷 / 12期
关键词：
diagnosis; disease; drug resistance; epidemiology; genetic variation; genomic medicine; individualized medicine; microRNA; miRNA; miRSNP; mutations; ncRNA; noncoding RNA; personalized medicine; pharmacogenomics; polymorphisms; prognosis; BREAST-CANCER; DIHYDROFOLATE-REDUCTASE; MICRORNA POLYMORPHISMS; TAMOXIFEN RESISTANCE; OVARIAN-CANCER; EXPRESSION; CELL; GENES; PHARMACOGENOMICS; INVOLVEMENT;
D O I：
10.2217/PGS.12.121
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1321 / 1324
页数：4
相关论文
共 37 条
  • [1] ALT FW, 1978, J BIOL CHEM, V253, P1357
  • [2] Pharmacogenomics of microRNA: a miRSNP towards individualized therapy
    Bertino, Joseph R.
    Banerjee, Debabrata
    Mishra, Prasun J.
    [J]. PHARMACOGENOMICS, 2007, 8 (12) : 1625 - 1627
  • [3] MicroRNAs modulate the chemosensitivity of tumor cells
    Blower, Paul E.
    Chung, Ji-Hyun
    Verducci, Joseph S.
    Lin, Shili
    Park, Jong-Kook
    Dai, Zunyan
    Liu, Chang-Gong
    Schmittgen, Thomas D.
    Reinhold, William C.
    Croce, Carlo M.
    Weinstein, John N.
    Sadee, Wolfgang
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (01) : 1 - 9
  • [4] Hyaluronan-CD44 Interaction with Protein Kinase Cε Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
    Bourguignon, Lilly Y. W.
    Spevak, Christina C.
    Wong, Gabriel
    Xia, Weiliang
    Gilad, Eli
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (39) : 26533 - 26546
  • [5] Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
    Calin, GA
    Dumitru, CD
    Shimizu, M
    Bichi, R
    Zupo, S
    Noch, E
    Aldler, H
    Rattan, S
    Keating, M
    Rai, K
    Rassenti, L
    Kipps, T
    Negrini, M
    Bullrich, F
    Croce, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) : 15524 - 15529
  • [6] MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
    Calin, GA
    Liu, CG
    Sevignani, C
    Ferracin, M
    Felli, N
    Dumitru, CD
    Shimizu, M
    Cimmino, A
    Zupo, S
    Dono, M
    Dell'Aquila, ML
    Alder, H
    Rassenti, L
    Kipps, TJ
    Bullrich, F
    Negrini, M
    Croce, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) : 11755 - 11760
  • [7] MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
    Cochrane, Dawn R.
    Spoelstra, Nicole S.
    Howe, Erin N.
    Nordeen, Steven K.
    Richer, Jennifer K.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (05) : 1055 - 1066
  • [8] A vision for the future of genomics research
    Collins, FS
    Green, ED
    Guttmacher, AE
    Guyer, MS
    [J]. NATURE, 2003, 422 (6934) : 835 - 847
  • [9] Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
    Eitan, Ram
    Kushnir, Michal
    Lithwick-Yanai, Gila
    Ben David, Miriam
    Hoshen, Moshe
    Glezerman, Marek
    Hod, Moshe
    Sabah, Gad
    Rosenwald, Shai
    Levavi, Hanoch
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 114 (02) : 253 - 259
  • [10] MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
    Garofalo, M.
    Quintavalle, C.
    Di Leva, G.
    Zanca, C.
    Romano, G.
    Taccioli, C.
    Liu, C. G.
    Croce, C. M.
    Condorelli, G.
    [J]. ONCOGENE, 2008, 27 (27) : 3845 - 3855
1234